Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study

The Lancet Oncology
Melissa A MerrittShelley S Tworoger

Abstract

Ovarian cancer is the fifth most common cause of cancer death among women in the USA. In this study, our objective was to determine whether modifiable exposures to common analgesics outside of standard treatment influence prognosis in patients with ovarian cancer. The Nurses' Health Study (NHS) and Nurses' Health Study II (NHSII) are ongoing prospective studies of 121 700 and 116 429 US nurses who have completed biennial questionnaires since 1976 and 1989, respectively. We retrieved information from medical records, death certificates, or linkage to a state or Surveillance, Epidemiology, and End Results (SEER) cancer registry on ovarian cancer cases. Eligible participants had confirmed invasive, stage I-III epithelial ovarian cancer, and had data available on analgesic use. The primary objective was to determine whether self-reported regular use (≥2 days per week) of aspirin, non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs), or paracetamol before and after ovarian cancer diagnosis, was associated with ovarian cancer-specific survival. We used Cox proportional hazards regression to calculate hazard ratios (HRs) and 95% CIs for these associations, adjusting for age and year of diagnosis, disease stage, and histology. Be...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Dec 1, 1994·American Journal of Epidemiology·J W Rich-EdwardsM J Stampfer
Aug 13, 1998·Journal of the National Cancer Institute·B RockhillG A Colditz
Jan 25, 2003·BMJ : British Medical Journal·Douglas G Altman, J Martin Bland
May 3, 2005·Nature Reviews. Cancer·Graham A Colditz, Susan E Hankinson
Jul 16, 2005·Journal of Internal Medicine·D Pereg, M Lishner
Feb 24, 2006·Nature Reviews. Cancer·Cornelia M UlrichJohn D Potter
Aug 13, 2009·JAMA : the Journal of the American Medical Association·Andrew T ChanCharles S Fuchs
Feb 18, 2012·The New England Journal of Medicine·Rebecca L StoneAnil K Sood
Feb 22, 2012·Cytokine·Antonio Macciò, Clelia Madeddu
May 18, 2012·Current Pharmaceutical Design·Eveline M DijkgraafJudith R Kroep
Oct 26, 2012·The New England Journal of Medicine·Xiaoyun LiaoShuji Ogino
Jun 12, 2013·Gynecologic Oncology·S K AllensworthJ N Bakkum-Gamez
Nov 14, 2013·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Jaime Prat, UNKNOWN FIGO Committee on Gynecologic Oncology
Apr 29, 2014·Lancet·Gordon C JaysonJonathan A Ledermann
Jul 16, 2014·Seminars in Oncology·Ashley N DavisAnil K Sood
Jul 28, 2016·American Journal of Public Health·Ying BaoJorge E Chavarro
Nov 29, 2016·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Daniel BarAyelet Shai
Jan 10, 2018·British Journal of Cancer·Freija VerdoodtSøren Friis

❮ Previous
Next ❯

Citations

May 18, 2019·CA: a Cancer Journal for Clinicians·Stephanie LheureuxAmit M Oza
Jul 28, 2019·Cancers·Laurie G HudsonAngela Wandinger-Ness
Dec 19, 2019·Current Opinion in Obstetrics & Gynecology·Mohana Roy, Kavitha Ramchandran
May 29, 2019·Obstetrics and Gynecology·Ana I Tergas, Jason D Wright
Nov 7, 2019·International Journal of Cancer. Journal International Du Cancer·Tianyi WangShelley S Tworoger
Aug 18, 2020·F1000Research·Qurratulann AlviAli Dabbagh
Feb 26, 2019·Journal of Gynecologic Oncology·Miseon KimJae Weon Kim
May 14, 2020·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Fu XiaomengYuan Dandan
Oct 7, 2020·Women's Health·Nalinie Joharatnam-HoganRuth E Langley
Nov 5, 2020·International Journal of Molecular Sciences·Demetra H HufnagelAlicia Beeghly-Fadiel
Feb 19, 2021·Frontiers in Oncology·Xiaxia ManSongling Zhang
Apr 16, 2021·Cancer Management and Research·Tao GuoLin Zhang
Mar 4, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Naoko SasamotoHolly R Harris
May 9, 2021·International Journal of Cancer. Journal International Du Cancer·Tianyi WangShelley S Tworoger
Aug 7, 2021·Biomolecules·Chao-Lien LiuTsui-Lien Mao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.